Sanofi Synthelabo

Sanofi-Synthélabo is present in over 100 countries. In Europe, the group has subsidiaries in every country. In the United States, the group operates via a subsidiary, an alliance, a joint venture and license agreements. In Japan, its products are marketed via joint ventures and license agreements.Sanofi-Synthélabo est déjà très implanté en Europe.

Activity:

- Manufacturing

Product / Technology type(s) covered:

- NCE (new chemical entities)
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)

Therapeutic targets:

- Cardiovascular
- Central nervous system
- Oncology

Markets Covered

a. HeadQuarter: France

b. Continent(s) active: Europe , North America , Asia

c. Countries active:

Corporate data:

Number of Employees: 30514

Turnover:

Amount:	Year:	Currency:
6488000000	2001	Euro

Year founded: